Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China
· Delayed Price · Currency is CNY 5.19
+0.02 (0.39%)
Mar 10, 2026, 11:25 AM CST
SHE:300006 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -107.3 | -87.8 | -8.93 | -68.71 | -100.53 | -326.76 | Upgrade
|
| Depreciation & Amortization | 54.47 | 54.47 | 72.77 | 76.41 | 74.76 | 108.78 | Upgrade
|
| Other Amortization | 2.59 | 2.59 | 2.65 | 1.78 | 1.42 | 1.59 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.49 | -0.49 | -0.45 | -0.25 | 0.03 | -0.65 | Upgrade
|
| Asset Writedown & Restructuring Costs | 25.75 | 25.75 | 0.71 | 0.09 | 0.51 | 166.82 | Upgrade
|
| Loss (Gain) From Sale of Investments | 18.88 | 18.88 | -85.74 | -5.78 | -47.92 | 32.8 | Upgrade
|
| Provision & Write-off of Bad Debts | 2.06 | 2.06 | -1.69 | -5.59 | -1.42 | 2.83 | Upgrade
|
| Other Operating Activities | -158.21 | 6.98 | -14.59 | 44.54 | 66.98 | 101.7 | Upgrade
|
| Change in Accounts Receivable | 239.87 | 239.87 | 51.39 | 142.18 | -54.29 | 167 | Upgrade
|
| Change in Inventory | 0.99 | 0.99 | 27.64 | -46.66 | 63.34 | 13.49 | Upgrade
|
| Change in Accounts Payable | -75.35 | -75.35 | -50.76 | -20.24 | 118.1 | -33.47 | Upgrade
|
| Change in Other Net Operating Assets | -0.3 | -0.3 | 82.59 | -51.46 | - | - | Upgrade
|
| Operating Cash Flow | 0.33 | 185.03 | 81.53 | 57.13 | 108.28 | 224.54 | Upgrade
|
| Operating Cash Flow Growth | -99.85% | 126.94% | 42.70% | -47.24% | -51.78% | -2.92% | Upgrade
|
| Capital Expenditures | -51.19 | -78.62 | -59.32 | -68.18 | -38.66 | -44.53 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.19 | 0.04 | 0.16 | 0 | 0.74 | 0.01 | Upgrade
|
| Cash Acquisitions | -11.01 | -11.01 | - | - | - | - | Upgrade
|
| Divestitures | 0.78 | - | -12.29 | - | 78.12 | - | Upgrade
|
| Investment in Securities | 44.57 | 64.22 | -60.29 | 80.2 | 114.3 | -73.46 | Upgrade
|
| Other Investing Activities | -53.04 | 7.07 | 4.64 | 1.81 | 2.69 | 7.02 | Upgrade
|
| Investing Cash Flow | -69.69 | -18.31 | -127.11 | 13.82 | 157.19 | -110.97 | Upgrade
|
| Long-Term Debt Issued | - | 391.6 | 294.9 | 352.5 | 171 | 1,733 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -180.91 | - | Upgrade
|
| Long-Term Debt Repaid | - | -181.23 | -362.86 | -206.88 | -1,084 | -1,417 | Upgrade
|
| Total Debt Repaid | -302.6 | -181.23 | -362.86 | -206.88 | -1,265 | -1,417 | Upgrade
|
| Net Debt Issued (Repaid) | 102.85 | 210.37 | -67.96 | 145.62 | -1,094 | 315.98 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1,065 | - | Upgrade
|
| Common Dividends Paid | -7.93 | -10.76 | -11.8 | -17.47 | -29.08 | -111.41 | Upgrade
|
| Other Financing Activities | -12.58 | -9.67 | -1.48 | 37.91 | 94.2 | -265.93 | Upgrade
|
| Financing Cash Flow | 82.34 | 189.94 | -81.24 | 166.07 | 36.05 | -61.37 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.56 | 0.44 | 0.57 | 2.77 | -0.86 | -1.12 | Upgrade
|
| Net Cash Flow | 13.53 | 357.1 | -126.25 | 239.79 | 300.67 | 51.08 | Upgrade
|
| Free Cash Flow | -50.86 | 106.41 | 22.21 | -11.05 | 69.63 | 180.01 | Upgrade
|
| Free Cash Flow Growth | - | 379.04% | - | - | -61.32% | 7.00% | Upgrade
|
| Free Cash Flow Margin | -6.60% | 13.37% | 2.48% | -1.25% | 5.68% | 11.37% | Upgrade
|
| Free Cash Flow Per Share | -0.05 | 0.10 | 0.02 | -0.01 | 0.07 | 0.22 | Upgrade
|
| Cash Income Tax Paid | 87.12 | 126.87 | 132.63 | 114.96 | 166.12 | 202.08 | Upgrade
|
| Levered Free Cash Flow | -53.15 | 68.32 | 17.68 | 211.44 | -66.92 | 52.62 | Upgrade
|
| Unlevered Free Cash Flow | -44.63 | 75.28 | 25.48 | 224.16 | -46.87 | 104.61 | Upgrade
|
| Change in Working Capital | 162.6 | 162.6 | 116.79 | 14.64 | 114.46 | 137.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.